Stemson Therapeutics is pioneering a groundbreaking approach to hair restoration by focusing on the creation of new hair follicles rather than merely reviving existing ones. The company is developing a revolutionary cell therapy that utilizes Induced Pluripotent Stem Cells (iPSC) to generate Dermal Papilla cells, which are essential for hair follicle formation. This innovative technology aims to provide a true cure for hair loss, addressing the limitations of current treatments that primarily target damaged or shrinking follicles. By leveraging advanced techniques at the Sanford Burnham Prebys Medical Discovery Institute, Stemson is committed to delivering effective solutions for individuals suffering from various forms of hair loss.

Recently, Stemson Therapeutics announced a significant technological breakthrough that positions its proprietary hair rejuvenation solution for human clinical trials. The company has successfully created human hair follicles in humanized mice using engineered follicular units (EFUs), which serve as an unlimited source of hair follicle replacements. This advancement allows Stemson to target a wide range of hair loss conditions, including Androgenetic Alopecia, Scarring Alopecia, and Chemo-Induced Alopecia. With a dedicated team of scientists and collaborators, Stemson is focused on translating its scientific innovations into clinically tested therapies that can significantly improve the lives of those affected by hair loss.

United States

At Stemson Therapeutics, we envision a world where anyone battling the emotional trauma or social stigma of hair loss has an opportunity to truly cure their condition and safely restore their natural hair.

Stemson Therapeutics

Company Details